The infection with the SARS-CoV-2 virus is associated with numerous systemic
involvements. Besides the severe respiratory injuries and cardiovascular complications, it …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative
pathogen of a new infectious disease, coronavirus disease 2019 (COVID-19), that first …

Coronavirus disease 2019 (COVID-19) increases the risk of thromboembolic events,
especially in patients with severe infections requiring intensive care and cardiorespiratory …

The novel coronavirus 2019 (COVID-19) is clinically characterized by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for a high number …

Long-coronavirus disease 2019 (COVID-19) represents a heterogeneous clinical syndrome
characterized by a pathologic continuum of signs, symptoms, and also laboratory/radiologic …

The novel coronavirus, SARS-CoV-2, is causing a global pandemic of life-threatening
multiorgan disease, called COVID-19. Accumulating evidence indicates that patients with …

The high incidence of thromboembolic disease, and in particular venous thromboembolism
(VTE), has emerged as an important consideration in hospitalized and critically ill patients …

The novel Corona virus infection (Covid-19) first identified in China in December 2019 has
rapidly progressed in pandemic leading to significant mortality and unprecedented …

Background Evidence supports an excess of deaths during the COVID-19 pandemic. We
report the incidence and mortality of thrombo-embolic events (TE) during the COVID-19 …

The cardinal pathology of coronavirus disease 2019 (COVID-19) is a primary infection of
pulmonary tract cells by severe acute respiratory syndrome coronavirus 2, provoking a local …